-
®Revlimid
Understanding Revlimid Therapy
IMF
"
'
.
,
.
©2007, International Myeloma Foundation,
North Hollywood, California
5
5
?
7
9 ?
15
?
22
23
23
24
28
-
"
4
4
5
Revlimid
,
)Lenalidimide(
:
.
.
.
.
?
.
,
(
.)
:
,
.
,
.
.
5
.
,
.
,
,
,Monoclonal protein (M. Protein(-
.
,
.
,
,
.
.
.
.
,
,
,
.
,
,
.
6
:)
(
1
.
,
.
,
.
:)
(
2
3
1
:)
(
3
:
.
.
b2
microglobulin
.
,
.
.
.
,
,
7
.
.
,""
,
,
,
.
65
.
65
.
,
,
.
,
. )(
,
8
9
8
?
.
,
.
,
.
,
/
.
-
(
NK -
T
,T
)Natural Killer
.
.
.
,
,
,
"
, -
(
.)
9
,
,
,
.
,
,
,
.
,
.
.
10
10
11
"
,
,
. 97-
704
25
"
.
,9-12 ,17-20
"
40
. 28
,1-4
,
, .
1-4
"
40-
"
25
. 28
1-21
,
, .
,
.
.
,
21.9%
60% -
.
.
.
11
.
,
"
.
, .
.
12
.
90% -
,
,
.
.
,
.
.
13
12
13
,
:
)6%(
,)15%(
.)6%(
,
.
,)
(
.
.
14
15
,
222- .
,1-21
,
"
30
. 28
.
71%
.
. 22.4
,
)(
.)(
,
.
,
,
.
?
.
.
.
15
,
.
,
,
,
,
.
,
, .
.
.
16
16
17
,
.
·
·
·
·
·
·
)FDA(
(
,
)
,
,
.
17
:
,
.
-
:
.
;
,
.
:
.
.
-
:
.
.
,
.
18
:
.
,
"
.
.
"
.
.
,G-CSF
.
19
18
19
"
.
,
.
:
,
.
:
"
.
.
,
,
.
,
20
(DVT) Deep Vein Thrombosis
"
.
.
.
.
,
,
,
/
.
:
, ,
.
.
,
,
.
21
,
,
,
.
,
.
,
.
:
,
.
.
.
,
.
.
,
, ,
,
,
,
22
.
,
.
,
.
?
.
"
25
28
1-21
.
22-28
,
.
,
,
.
.
," 25
.
,
.
23
,
-
.
-
,
.
-
.
- :
,
.
-
,
.
-
,
.
-
Monoclonal protein (M protein)
,
"
.
.
24
-
,
.
:Red blood cell -
.
"
-
,
.
-
B -
,
T-
.
.)NK - cell) natural killer cells
.
,
-
,
,
.
-
.
,
.
25
"
-
.
-
,
, ,
/
.
/
.
-
-
. ,
-
.
(growth factor)
-
,T -
"
.B - T -
-
.
,
-
,
.
26
-
.
"
,
"
.
-
.
,
.
27
.)IMF(
"
/
)IMF(
.
28
. 6429 ..
.
:
052-8812640
'
29
,
,
,
,
,
.
,
.
.
,
-
.
,
,
30
.
.
:
052-2587612
:
052-3961210
:
054-5965596 :
054-4348499 :
.
31